Global Anticoagulants Market Analysis Market Size and Growth The global anticoagulants market is projected to grow from USD 37.69 billion in 2024 to USD 80.29 billion by 2032, with a compound annual growth rate (CAGR) of 9.9%. Regional Analysis North America dominates the market with a 50.14% share in 2024, driven by high cardiovascular disease prevalence and new product launches. Europe is expected to grow at a CAGR of 7.6%, while China shows strong potential with a projected CAGR of 13.40%. Key Market Segments By Disease Indication Pulmonary Embolism (PE) segment leads the market Expected to generate USD 31.53 billion in revenue by 2025 Growth driven by increasing prevalence of PE and related conditions By Distribution Channel Hospital pharmacies hold the largest share (46.1% expected in 2025) Retail pharmacies maintain second position Online pharmacies show highest growth potential By Route of Administration Oral anticoagulants dominate the market Injectable segment maintains presence through warfarin products Market Drivers Rising cardiovascular disease prevalence globally Increased awareness of cardiovascular health Introduction of novel oral anticoagulants (NOACs) Technological advances in drug development Regional Highlights Japan market expected to reach USD 3.21 billion by 2025 Latin America shows robust growth potential Middle East and Africa anticipate steady market expansion Report- Fortune Business Insights - Anticoagulants Market Size, Share, Trends, Forecast, 2032 https://www.fortunebusinessinsights.com/industry-reports/anticoagulants-market-101807